BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25310982)

  • 1. mTORC1 controls PNS myelination along the mTORC1-RXRγ-SREBP-lipid biosynthesis axis in Schwann cells.
    Norrmén C; Figlia G; Lebrun-Julien F; Pereira JA; Trötzmüller M; Köfeler HC; Rantanen V; Wessig C; van Deijk AL; Smit AB; Verheijen MH; Rüegg MA; Hall MN; Suter U
    Cell Rep; 2014 Oct; 9(2):646-60. PubMed ID: 25310982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 Is Transiently Reactivated in Injured Nerves to Promote c-Jun Elevation and Schwann Cell Dedifferentiation.
    Norrmén C; Figlia G; Pfistner P; Pereira JA; Bachofner S; Suter U
    J Neurosci; 2018 May; 38(20):4811-4828. PubMed ID: 29695414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual function of the PI3K-Akt-mTORC1 axis in myelination of the peripheral nervous system.
    Figlia G; Norrmén C; Pereira JA; Gerber D; Suter U
    Elife; 2017 Sep; 6():. PubMed ID: 28880149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.
    Furusho M; Ishii A; Bansal R
    J Neurosci; 2017 Mar; 37(11):2931-2946. PubMed ID: 28193689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt/mTOR signalling in myelination.
    Norrmén C; Suter U
    Biochem Soc Trans; 2013 Aug; 41(4):944-50. PubMed ID: 23863161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fisetin regulates obesity by targeting mTORC1 signaling.
    Jung CH; Kim H; Ahn J; Jeon TI; Lee DH; Ha TY
    J Nutr Biochem; 2013 Aug; 24(8):1547-54. PubMed ID: 23517912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination.
    Lebrun-Julien F; Bachmann L; Norrmén C; Trötzmüller M; Köfeler H; Rüegg MA; Hall MN; Suter U
    J Neurosci; 2014 Jun; 34(25):8432-48. PubMed ID: 24948799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF-1 stimulates de novo fatty acid biosynthesis by Schwann cells during myelination.
    Liang G; Cline GW; Macica CM
    Glia; 2007 Apr; 55(6):632-41. PubMed ID: 17299765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mTORC1 is essential for early steps during Schwann cell differentiation of amniotic fluid stem cells and regulates lipogenic gene expression.
    Preitschopf A; Li K; Schörghofer D; Kinslechner K; Schütz B; Thi Thanh Pham H; Rosner M; Joo GJ; Röhrl C; Weichhart T; Stangl H; Lubec G; Hengstschläger M; Mikula M
    PLoS One; 2014; 9(9):e107004. PubMed ID: 25221943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
    Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
    Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic PI3K and K-Ras stimulate de novo lipid synthesis through mTORC1 and SREBP.
    Ricoult SJ; Yecies JL; Ben-Sahra I; Manning BD
    Oncogene; 2016 Mar; 35(10):1250-60. PubMed ID: 26028026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination.
    Bercury KK; Dai J; Sachs HH; Ahrendsen JT; Wood TL; Macklin WB
    J Neurosci; 2014 Mar; 34(13):4466-80. PubMed ID: 24671993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer.
    Wazir U; Newbold RF; Jiang WG; Sharma AK; Mokbel K
    Oncol Rep; 2013 May; 29(5):1969-74. PubMed ID: 23503572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and association of mTOR with its cofactors, raptor and rictor, in cumulus cells and oocytes during meiotic maturation in mice.
    Kogasaka Y; Hoshino Y; Hiradate Y; Tanemura K; Sato E
    Mol Reprod Dev; 2013 Apr; 80(4):334-48. PubMed ID: 23440873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
    Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
    Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SREBP-1c expression in Schwann cells is affected by diabetes and nutritional status.
    de Preux AS; Goosen K; Zhang W; Sima AA; Shimano H; Ouwens DM; Diamant M; Hillebrands JL; Rozing J; Lemke G; Beckmann JS; Smit AB; Verheijen MH; Chrast R
    Mol Cell Neurosci; 2007 Aug; 35(4):525-34. PubMed ID: 17632011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profilin 1 is required for peripheral nervous system myelination.
    Montani L; Buerki-Thurnherr T; de Faria JP; Pereira JA; Dias NG; Fernandes R; Gonçalves AF; Braun A; Benninger Y; Böttcher RT; Costell M; Nave KA; Franklin RJ; Meijer D; Suter U; Relvas JB
    Development; 2014 Apr; 141(7):1553-61. PubMed ID: 24598164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal miR-673-5p from fibroblasts promotes Schwann cell-mediated peripheral neuron myelination by targeting the TSC2/mTORC1/SREBP2 axis.
    Zhao Y; Liang Y; Xu Z; Liu J; Liu X; Ma J; Sun C; Yang Y
    J Biol Chem; 2022 Mar; 298(3):101718. PubMed ID: 35151688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Connecting mTORC1 signaling to SREBP-1 activation.
    Bakan I; Laplante M
    Curr Opin Lipidol; 2012 Jun; 23(3):226-234. PubMed ID: 22449814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination.
    Ishii A; Furusho M; Bansal R
    Glia; 2021 Oct; 69(10):2429-2446. PubMed ID: 34157170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.